Home > Healthcare > Medical Devices > Rehabilitation and Assistive Devices > Neurorehabilitation Devices Market

Neurorehabilitation Devices Market Size

  • Report ID: GMI7702
  • Published Date: Dec 2023
  • Report Format: PDF

Neurorehabilitation Devices Market Size

Neurorehabilitation Devices Market was valued at USD 1.9 billion in 2023 and is anticipated to grow at a CAGR of over 13.4% between 2024 and 2032. Neurorehabilitation devices refer to a category of medical devices designed to aid in the rehabilitation and recovery of individuals with neurological disorders or injuries. The rising prevalence of neurological disorders is anticipated to augment the market growth. Globally, one in four individuals face the risk of experiencing a stroke in their lifetime, as per the World Health Organization (WHO). Additionally, as per statistics, an estimated 1.8 million people are affected by multiple sclerosis in 2023, while over 10 million individuals suffer with Parkinson's disease worldwide. Thus, as the incidence of neurological disorders increases globally, there is a growing demand for effective rehabilitation solutions to address the resulting impairments and disabilities, thereby stimulating market growth.

 

Furthermore, ongoing technological advances are pivotal in developing innovative neurotech devices, such as EksoNR Robotic Exoskeletons, InMotion Robotics, BrainRobotics hand (brain-computer interfaces), virtual reality, and wearable medical devices, which is estimated to reach USD 750 billion by 2032. These state-of-the-art technologies contribute significantly to more personalized and engaging rehabilitation interventions, enhancing patient outcomes through sophisticated and tailored approaches.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for neurorehabilitation devices was valued at USD 1.9 billion in 2023 and is estimated to reach USD 5.8 billion by 2032 as they are designed to aid in the rehabilitation and recovery of individuals with neurological disorders or injuries.

The neurorobotics segment of neurorehabilitation devices industry garnered USD 604 million in 2023 and will grow significantly through 2032 as these devices enable intensive and repetitive training, promoting neuroplasticity and functional recovery.

The U.S. neurorehabilitation devices market accounted for USD 693 million in 2023 and is predicted to witness substantial growth through 2032 attributed to the country's advanced healthcare infrastructure, a robust R&D landscape, and a high prevalence of neurological disorders.

Bioventus LLC, Ectron Ltd., Hocoma (DIH Medical), BIOMETRICS LTD., Bionik Laboratories Corp., BioXtreme Ltd., Ekso bionics holdings, Inc., Kinestica, Saebo, Inc., Abbott Laboratories, Emotiv Inc., BrainCo, Inc, Permobil AB, and Medtronic Plc.

Neurorehabilitation Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 221
  • Countries covered: 22
  • Pages: 143
 Download Free Sample